PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Chemistry & Biology

Topics

Biology

Artificial Intelligence

Computer Science

Biochemistry

Cancer Oncology

Show all topics

DOI

10.1016/j.chembiol.2013.05.010

License

publisher-specific-oa